Cardionovum

Be up
to date.

Latest press release

APERTO®, our innovative paclitaxel coated balloon for arterio-venous access, has received market approval for China. It is the the first high pressure drug coated balloon available in China to treat obstructive lesions of native Arterio Venous Dialysis Fistulae.

The approval was given based on the statistic results from the solidly designed clinical study in Chinese population:
APERTO AVF RCT CHINA.

European Key Opinion Leaders as guests:

  • Prof. Dr. Horst Sievert , Frankfurt, Germany
  • Prof. Dr. Giuseppe Tarantini, Padua, Italy
  • Prof. Dr. Jacques Blacher, Paris, France

Video of European guests' speech.

RESTORE®, CARDIONOVUM’s innovative paclitaxel-coated balloon for coronary applications has received market approval for China, making it the first drug-coated balloon (DCB) available in China to treat two indications: in-stent restenosis (ISR) and small vessel disease (SVD). The approval was given based on the impressive results from two solidly designed clinical studies in Chinese populations: RESTORE ISR CHINA and RESTORE SVD CHINA.

Upcoming events

Cardionovum® at EuroPCR 2024

Cardionovum® is pleased to invite you to visit us at booth #M14.

Location:

Palais des Congrès de Paris
2 Place Porte Maillot
Paris - FRANCE

Date: May 14, 2024–May 17, 2024

Cardionovum® at LINC 2024

Cardionovum® is pleased to invite you to visit us at booth #309.

Location:

Leipziger Messe GmbH
Messe-Allee 1
04356 Leipzig

Date: May 28, 2024–May 31, 2024

Latest events

Cardionovum at CIRSE 2021

Cardionovum invites you to participate in 3 scientific presentations in the "Technology Innovations Videos":

  • Sunday 26th
    The SAFEPAX Technology presented by Dr. Michael Lichtenberg.

  • Monday 27th
    The Reflow Study at 2 years follow up. by Dr. Marc Bosiers.

  • Tuesday 28th
    Clinical outcomes with APERTO Balloon. by Dr. Matteo Tozzi.

Date: Sep 25, 2021–Sep 28, 2021

Learn more >>

Cardionovum at EuroPCR 18, 19, 20 May 2021

Cardionovum invites you to participate in on demand interviwes:

  • XLIMIT Trial RCT, with Dr. Luca Testa from Italy.
    Goal: to assess angiographic and clinical performance of the Xlimus Biodegradable Polymer Sirolumus-eluting stent versus a gold standard like Synergy Biodegradable Polymer Everolimus Stent in patients treated with percutaneous coronary angioplasty.

  • Hyper Registry with Dr. Alfonso Ileasi from Italy.
    Goal: Asses the clinical results after a Hybrid Approach in diffuse CAD lesions longer tan 28mm combinig Restore DCB and New generation DES.

Date: May 18, 2021–May 20, 2021

Learn more >>

Cardionovum - Meeting & Symposium at LINC 2020

Cardionovum participates at LINC
Leipzig Interventional Course
You are welcome to visit us at booth no. 19 c

Date: Jan 28, 2020–Jan 31, 2020

Location: Leipzig, Germany

Learn more >>

Visit website >>

go top